Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D002851:Chromatography, High Pressure Liquid; D004337:Drug Carriers; D016503:Drug Delivery Systems / Q000379:methods*; D005290:Ferric Compounds / Q000493:pharmacokinetics*; D007457:Iodine Radioisotopes; D007504:Iron Radioisotopes; D008280:Magnetics; D008942:Mitoxantrone / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D036103:Nanotechnology; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D010316:Particle Size; D011817:Rabbits
D000970:Antineoplastic Agents; D004337:Drug Carriers; D005290:Ferric Compounds; D007457:Iodine Radioisotopes; D007504:Iron Radioisotopes; D008942:Mitoxantrone